Advancing discovery through Alluvi research

Alluvi Labs develops and evaluates
premium peptides, supplements,
‍
All products are produced exclusively
for controlled research and development purposes, guided by science.
Not for human or veterinary consumption.

Alluvi

Labs

App Webflow Template -
Black Zero - Created by Wedoflow.com and Azwedo.com

Engineered for research precision.

Wholesale With Alluvi

Retatrutide – Pre-Filled Pen Evaluation

Part of Alluvi Labs’ ongoing research program into advanced GLP-1 multi-agonist compounds.
This formulation is supplied in controlled batches for laboratory analysis of stability, compound behaviour, and injector system performance.
Not for human or veterinary consumption.

Track. Dose. Progress.

The Alluvi app supports wellness goals with smart tracking, log nutrition, monitor weight, and stay consistent through a modern mobile dashboard.

Recovery Meets Routine

_{Daily gummy supplements crafted for sleep, stress support, and muscle recovery, for rest and protein for strength, all in a clean, delicious form.}

Power-Up in a Gummy

A delicious way to fuel your body with protein and creatine – Alluvi Gummy Bears are a quick, convenient solution to stay on top of daily nutrients. No scoops. No shakes. Just results.

No prep. No hassle.
Just precision dosing.

Alluvi pens are supplied ready-to-use – no mixing, no guesswork.
Developed for controlled research applications, each unit features fixed pre-measured volumes to support consistency and reliability during laboratory evaluation.
Not for human or veterinary consumption.

Track Data. Refine Research.

From peptide pens to supplement gummies, Alluvi’s systems support the collection of research data, structured logging, and weekly measurement summaries – enabling consistent evaluation as part of controlled research and development programs.
Not for human or veterinary consumption.

Proven Data. Backed by Research.

Published studies have investigated GLP-1 multi-agonist compounds under controlled conditions.
Alluvi supplies Retatrutide pens exclusively for laboratory research and development.
Not for human or veterinary consumption.

All figures are derived from third party published studies and are shown only for academic context. All Alluvi products are supplied strictly for laboratory research purposes.

22.5%

loss in weight using Retatrutide

Reference value drawn from published research on GLP-1 multi-agonist compounds.
Provided strictly as scientific context.

6oo

Clinical Study based on 600 calorie reduction in daily intake

Participants consumed fewer calories per day without being instructed to diet – driven by decreased appetite and satiety signaling.
Provided strictly as scientific context.

28%

Reported increased energy levels in trials

Reported value in published research relating to GLP-1 multi-agonist compounds.
Provided strictly as a scientific reference point.

18.3 KG

Average weight loss during clinical trial period of 48 weeks on high-dose Retatrutide.

Example data point referenced in peer-reviewed studies for GLP-1 multi-agonists.
Alluvi does not promote or imply medical use of its products.

The Alluvi AI App is Coming Soon

Start your free trial soon and see how easy it is to track, manage, and optimize your time.

More than peptides.
A Complete Research Platform.

From research-grade compounds to structured data collection and nutritional analysis – Alluvi provides an integrated system designed for controlled research and development programs.
Not for human or veterinary consumption.